Medneo accelerates growth and enters veterinary imaging with acquisition of Burgess Diagnostics
London, 21st September 2026 – Medneo today announced the acquisition of Burgess Diagnostics from Solingen Private Equity. Burgess a leading provider of mobile MRI and CT diagnostic imaging services to the veterinary sector.

The transaction marks Medneo’s first expansion into veterinary imaging and the latest step in a period of significant growth. It follows Medneo’s national partnership with Ramsay Health Care UK, broadening the group’s geographic reach, customer base and specialist imaging capabilities.
Established in 2003, Burgess Diagnostics provides advanced mobile MRI and CT imaging to veterinary practices, referral centres and specialist hospitals across the UK and Ireland. It has built a strong reputation for clinical expertise, innovation and service.
Burgess Diagnostics will continue to operate under its established brand, with continuity from the existing leadership team through the transition. Medneo will work alongside the Burgess team to support the business’s next phase of growth while preserving the expertise and customer relationships that have made it successful.
Ella Tracey, CEO of Medneo, said:
“Burgess is a significant addition to Medneo, bringing a leading specialist business into the group and taking us into veterinary imaging for the first time.”
“This acquisition demonstrates our ambition to build a broader, stronger imaging group. With the backing of CVC DIF, we look forward to working closely with the Burgess team, supporting its growth and building on more than 20 years of success.”
Mary Bronserud, Managing Director of Burgess Diagnostics, said:
“This is an exciting next chapter for Burgess Diagnostics. Medneo understands specialist imaging and shares our commitment to quality, innovation and excellent customer service.”
“Our clients will continue to work with the experienced team they know and trust. Becoming part of Medneo will give us additional support to build on our strong position and reach more veterinary organisations across the UK and Ireland.”
Paul Betts, on behalf of Solingen Private Equity, said:
“We are proud to have supported Burgess Diagnostics and its team as the business has developed its specialist services and strong reputation across the veterinary sector. We are delighted that Burgess is now joining Medneo, with the backing of CVC DIF, and wish both teams every success for the future.”
About Medneo
Medneo is a leading UK-wide provider of mobile diagnostic imaging services, operating a fleet of high-specification MRI and CT scanners and a flagship clinic in London. It is the only mobile diagnostic provider to hold both QSI accreditation and an ‘Outstanding’ rating from the CQC. Medneo employs more than 120 radiographers, with an average of eight years’ diagnostic experience, and delivers complex, radiographer-led Cardiac CT Tier 2 services. Medneo is executing a strategy focused on significant expansion across both NHS and private healthcare. The company has been recognised as “Great Place to Work” for five consecutive years.
About Burgess
Established in 2003, Burgess Diagnostics is a leading provider of mobile MRI and CT diagnostic imaging services to the veterinary sector. The company supports veterinary practices, referral centres and specialist hospitals across the UK and Ireland, providing advanced imaging through an experienced specialist team and a strong commitment to quality, innovation and customer service.

